Cholesterol in the Viral Membrane is a Molecular Switch Governing HIV‐1 Env Clustering

HIV‐1 entry requires the redistribution of envelope glycoproteins (Env) into a cluster and the presence of cholesterol (chol) in the viral membrane. However, the molecular mechanisms underlying the specific role of chol in infectivity and the driving force behind Env clustering remain unknown. Here, gp41 is demonstrated to directly interact with chol in the viral membrane via residues 751–854 in the cytoplasmic tail (CT751–854). Super‐resolution stimulated emission depletion (STED) nanoscopy analysis of Env distribution further demonstrates that both truncation of gp41 CT751–854 and depletion of chol leads to dispersion of Env clusters in the viral membrane and inhibition of virus entry. This work reveals a direct interaction of gp41 CT with chol and indicates that this interaction is an important orchestrator of Env clustering.

[1]  K. Salaita,et al.  Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters. , 2020, ACS nano.

[2]  J. Chou,et al.  Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein , 2020, Nature Communications.

[3]  Philip D. Plowright Front , 2019, 2020 Fourth World Conference on Smart Trends in Systems, Security and Sustainability (WorldS4).

[4]  J. Houtman,et al.  The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization , 2019, The Journal of Biological Chemistry.

[5]  S. V. van Engelenburg,et al.  Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation , 2019, Proceedings of the National Academy of Sciences.

[6]  H. Kräusslich,et al.  Quantification of phosphoinositides reveals strong enrichment of PIP2 in HIV-1 compared to producer cell membranes , 2019, Scientific Reports.

[7]  E. Freed,et al.  Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions , 2019, Journal of Virology.

[8]  M. Veit,et al.  Cholesterol Binding to the Transmembrane Region of a Group 2 Hemagglutinin (HA) of Influenza Virus Is Essential for Virus Replication, Affecting both Virus Assembly and HA Fusion Activity , 2019, Journal of Virology.

[9]  Marc C. Johnson,et al.  A lipid-based partitioning mechanism for selective incorporation of proteins into membranes of HIV particles , 2019, Nature Cell Biology.

[10]  J. A. Nieto-Garai,et al.  Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure , 2018, Front. Immunol..

[11]  D. Weissman,et al.  Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization , 2018, Virology.

[12]  R. E. Murphy,et al.  Solution Structure and Membrane Interaction of the Cytoplasmic Tail of HIV-1 gp41 Protein. , 2017, Structure.

[13]  J. Enderlein,et al.  Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state , 2017, Nature Communications.

[14]  F. Dumas,et al.  Lipids in infectious diseases - The case of AIDS and tuberculosis. , 2017, Biochimica et biophysica acta. Biomembranes.

[15]  R. Wyatt,et al.  Dense Array of Spikes on HIV-1 Virion Particles , 2017, Journal of Virology.

[16]  R. Böckmann,et al.  Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function , 2016, Front. Physiol..

[17]  F. Wieland,et al.  Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol , 2015, Nature Communications.

[18]  Benjamin K. Chen,et al.  HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail , 2015, Journal of Virology.

[19]  A. Trkola,et al.  Different Infectivity of HIV-1 Strains Is Linked to Number of Envelope Trimers Required for Entry , 2015, PLoS pathogens.

[20]  E. Freed,et al.  The role of matrix in HIV-1 envelope glycoprotein incorporation. , 2014, Trends in microbiology.

[21]  Charles R Sanders,et al.  Cholesterol as a co‐solvent and a ligand for membrane proteins , 2014, Protein science : a publication of the Protein Society.

[22]  G. Jennings,et al.  Evaluation of steroidal amines as lipid raft modulators and potential anti-influenza agents. , 2013, Bioorganic & medicinal chemistry letters.

[23]  Brent R. Martin Nonradioactive Analysis of Dynamic Protein Palmitoylation , 2013, Current protocols in protein science.

[24]  H. Schaal,et al.  Detection and initial characterization of protein entities consisting of the HIV glycoprotein cytoplasmic C-terminal domain alone. , 2013, Virology.

[25]  Hans-Georg Kräusslich,et al.  Comparative lipidomics analysis of HIV‐1 particles and their producer cell membrane in different cell lines , 2013, Cellular microbiology.

[26]  Thorsten Staudt,et al.  Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy , 2012, Science.

[27]  Baoshan Zhang,et al.  Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.

[28]  W. Sundquist,et al.  HIV-1 assembly, budding, and maturation. , 2012, Cold Spring Harbor perspectives in medicine.

[29]  E. Freed,et al.  HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. , 2011, Journal of molecular biology.

[30]  D. Tyrrell,et al.  Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses , 2010, Proceedings of the National Academy of Sciences.

[31]  Robert Damoiseaux,et al.  A broad-spectrum antiviral targeting entry of enveloped viruses , 2010, Proceedings of the National Academy of Sciences.

[32]  Polung Yang,et al.  The Cytoplasmic Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 Harbors Lipid Raft Association Determinants , 2009, Journal of Virology.

[33]  F. Wieland,et al.  Probing HIV-1 Membrane Liquid Order by Laurdan Staining Reveals Producer Cell-dependent Differences* , 2009, The Journal of Biological Chemistry.

[34]  Annick Thomas,et al.  Large changes in the CRAC segment of gp41 of HIV do not destroy fusion activity if the segment interacts with cholesterol. , 2008, Biochemistry.

[35]  S. S. Chen,et al.  Identification of the LWYIK Motif Located in the Human Immunodeficiency Virus Type 1 Transmembrane gp41 Protein as a Distinct Determinant for Viral Infection , 2008, Journal of Virology.

[36]  P. Uchil,et al.  Retroviruses Human Immunodeficiency Virus and Murine Leukemia Virus Are Enriched in Phosphoinositides , 2008, Journal of Virology.

[37]  K. Nagashima,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Assembly and Release by the Cholesterol-Binding Compound Amphotericin B Methyl Ester: Evidence for Vpu Dependence , 2008, Journal of Virology.

[38]  T. Veenstra,et al.  Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. , 2008, Biochemistry.

[39]  E. Freed,et al.  HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease , 2007, Proceedings of the National Academy of Sciences.

[40]  R. Ptak,et al.  Inhibition of HIV-1 Replication by Amphotericin B Methyl Ester , 2006, Journal of Biological Chemistry.

[41]  J. Lifson,et al.  Distribution and three-dimensional structure of AIDS virus envelope spikes , 2006, Nature.

[42]  J. Bhattacharya,et al.  Gag Regulates Association of Human Immunodeficiency Virus Type 1 Envelope with Detergent-Resistant Membranes , 2006, Journal of Virology.

[43]  Annick Thomas,et al.  Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. , 2006, Biochemistry.

[44]  Hans-Georg Kräusslich,et al.  The HIV lipidome: a raft with an unusual composition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Oliver T. Fackler,et al.  Construction and Characterization of a Fluorescently Labeled Infectious Human Immunodeficiency Virus Type 1 Derivative , 2004, Journal of Virology.

[46]  D. Graham,et al.  Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. , 2003, AIDS research and human retroviruses.

[47]  C. Genin,et al.  Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. , 2002, Biochimica et biophysica acta.

[48]  J. Mak,et al.  Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity , 2002, AIDS.

[49]  G. Lucero,et al.  A dominant block to HIV-1 replication at reverse transcription in simian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  W. Greene,et al.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.

[51]  S. Nir,et al.  Sphingomyelin and Cholesterol Promote HIV-1 gp41 Pretransmembrane Sequence Surface Aggregation and Membrane Restructuring* , 2002, The Journal of Biological Chemistry.

[52]  J. Hoxie,et al.  Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus , 2002, Journal of Virology.

[53]  H. Katinger,et al.  A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. , 2001, AIDS research and human retroviruses.

[54]  Dzung H. Nguyen,et al.  Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. , 2001, AIDS research and human retroviruses.

[55]  P. S. Kim,et al.  Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[57]  C. Martínez-A,et al.  Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection , 2000, EMBO reports.

[58]  H. Kräusslich,et al.  Biochemical and Structural Analysis of Isolated Mature Cores of Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.

[59]  E. Freed,et al.  The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Engelman,et al.  Caveolins, Liquid-Ordered Domains, and Signal Transduction , 1999, Molecular and Cellular Biology.

[61]  Xiao-Fang Yu,et al.  Highly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions , 1999, Journal of Virology.

[62]  Y. Shai,et al.  A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. , 1997, Biochemistry.

[63]  R. Compans,et al.  The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Zimmerberg,et al.  The hemifusion intermediate and its conversion to complete fusion: regulation by membrane composition. , 1995, Biophysical journal.

[65]  C. Rinaldo,et al.  Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. , 1993, Virology.

[66]  F. Jensen,et al.  Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Compans,et al.  Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. , 1992, The Journal of biological chemistry.

[68]  Deborah A. Brown,et al.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.

[69]  F. Jensen,et al.  Lipid composition and fluidity of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Y. Barenholz,et al.  Effect of cholesterol concentration on organization of viral and vesicle membranes. Probed by accessibility to cholesterol oxidase. , 1980, The Journal of biological chemistry.

[71]  F. Fahrenholz,et al.  Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles , 1999, Nature Cell Biology.

[72]  J. Moore,et al.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor , 1998, Nature Medicine.